AstraZeneca shareholders approve CEO Soriot’s contentious 2021 pay plan, defying wishes of 4 advisory groups

AstraZeneca shareholders approve CEO Soriot’s contentious 2021 pay plan, defying wishes of 4 advisory groups
nhigginsdunn
Tue, 05/11/2021 – 11:26